Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2023-2029

Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2023-2029

Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.

LPI (LP Information)' newest research report, the “Anti-Peptic Ulcer Drugs Industry Forecast” looks at past sales and reviews total world Anti-Peptic Ulcer Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-Peptic Ulcer Drugs sales for 2023 through 2029. With Anti-Peptic Ulcer Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Peptic Ulcer Drugs industry.

This Insight Report provides a comprehensive analysis of the global Anti-Peptic Ulcer Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Peptic Ulcer Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-Peptic Ulcer Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Peptic Ulcer Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Peptic Ulcer Drugs.

The global Anti-Peptic Ulcer Drugs market size is projected to grow from US$ 8523.5 million in 2022 to US$ 21200 million in 2029; it is expected to grow at a CAGR of 13.9% from 2023 to 2029.

Global Anti-Peptic Ulcer Drugs key players include AstraZeneca, Ask-pharm, Takeda, Yangtze River Pharm, Shandong Luoxin, etc. Global top five players hold a share about 50%.

In terms of product, the segment includes Proton Pump Inhibitors (PPIs), Potassium-Competitive Acid Blockers (P-CAB), Antacids, H2 Antagonists, Ulcer Protective Drugs. And in terms of application, the application includes Gastritis, Gastric Ulcers, Duodenal Ulcers, Gastroesophageal Reflux Disease (GERD).

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Peptic Ulcer Drugs market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

Proton Pump Inhibitors (PPIs)

Potassium-Competitive Acid Blockers (P-CAB)

Antacids

H2 Antagonists

Ulcer Protective Drugs

Segmentation by application

Gastritis

Gastric Ulcers

Duodenal Ulcers

Gastroesophageal Reflux Disease (GERD)

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

AstraZeneca

Ask-pharm

Takeda

Yangtze River Pharm

Shandong Luoxin

Huadong Medicine

Changzhou Siyao

Beijing Yuekang

Guangdong Dahua

Xian Janssen

Please note: The report will take approximately 2 business days to prepare and deliver.